These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33862617)

  • 1. Targeted antitumor comparison study between dopamine self-polymerization and traditional synthesis for nanoparticle surface modification in drug delivery.
    Zhang M; Zou Y; Zuo C; Ao H; Guo Y; Wang X; Han M
    Nanotechnology; 2021 May; 32(30):. PubMed ID: 33862617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modification of MPEG-b-PCL-based nanoparticles via oxidative self-polymerization of dopamine for malignant melanoma therapy.
    Xiong W; Peng L; Chen H; Li Q
    Int J Nanomedicine; 2015; 10():2985-96. PubMed ID: 25945046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing Targeted Therapy in Hepatocellular Carcinoma through a pH-Responsive Delivery System: Folic Acid-Modified Polydopamine-Paclitaxel-Loaded Poly(3-hydroxybutyrate-
    Wu M; Wang Q; Peng Y; Liang X; Lv X; Wang S; Zhong C
    Mol Pharm; 2024 Feb; 21(2):581-595. PubMed ID: 38131328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface modification of pH-sensitive honokiol nanoparticles based on dopamine coating for targeted therapy of breast cancer.
    Yu R; Zou Y; Liu B; Guo Y; Wang X; Han M
    Colloids Surf B Biointerfaces; 2019 May; 177():1-10. PubMed ID: 30690424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.
    Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z
    Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
    Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
    Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy.
    Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M
    Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polydopamine-based surface modification of paclitaxel nanoparticles for osteosarcoma targeted therapy.
    Zhao L; Bi D; Qi X; Guo Y; Yue F; Wang X; Han M
    Nanotechnology; 2019 Jun; 30(25):255101. PubMed ID: 30736019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy.
    Bi D; Zhao L; Li H; Guo Y; Wang X; Han M
    Int J Pharm; 2019 Mar; 559():76-85. PubMed ID: 30677481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Delivery of Gambogenic Acid by Functional Polydopamine Nanoparticles for Targeted Tumor Therapy.
    Wang B; Yuan T; Zha L; Liu Y; Chen W; Zhang C; Bao Y; Dong Q
    Mol Pharm; 2021 Mar; 18(3):1470-1479. PubMed ID: 33586444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.
    Yu B; Tang C; Yin C
    Biomaterials; 2014 Aug; 35(24):6369-78. PubMed ID: 24818887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
    Li S; Li X; Ding J; Han L; Guo X
    Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
    [No Abstract]   [Full Text] [Related]  

  • 14. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma.
    Wu M; Zhong C; Zhang Q; Wang L; Wang L; Liu Y; Zhang X; Zhao X
    J Nanobiotechnology; 2021 Feb; 19(1):39. PubMed ID: 33549107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
    Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
    Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo.
    Yao S; Li L; Su XT; Wang K; Lu ZJ; Yuan CZ; Feng JB; Yan S; Kong BH; Song K
    J Exp Clin Cancer Res; 2018 Feb; 37(1):29. PubMed ID: 29478415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione-sensitive and folate-targeted nanoparticles loaded with paclitaxel to enhance oral squamous cell carcinoma therapy.
    Fan L; Wang J; Xia C; Zhang Q; Pu Y; Chen L; Chen J; Wang Y
    J Mater Chem B; 2020 Apr; 8(15):3113-3122. PubMed ID: 32207763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles.
    Gui G; Fan Z; Ning Y; Yuan C; Zhang B; Xu Q
    Int J Nanomedicine; 2021; 16():2283-2295. PubMed ID: 33776433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.